Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

Por um escritor misterioso
Last updated 26 outubro 2024
Immunogenicity and risks associated with impaired immune responses  following SARS-CoV-2 vaccination and booster in hematologic malignancy  patients: an updated meta-analysis
Immunogenicity and risks associated with impaired immune responses  following SARS-CoV-2 vaccination and booster in hematologic malignancy  patients: an updated meta-analysis
Pathogens, Free Full-Text
Immunogenicity and risks associated with impaired immune responses  following SARS-CoV-2 vaccination and booster in hematologic malignancy  patients: an updated meta-analysis
COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies
Immunogenicity and risks associated with impaired immune responses  following SARS-CoV-2 vaccination and booster in hematologic malignancy  patients: an updated meta-analysis
Immunity to SARS‐CoV‐2 induced by infection or vaccination - Castro Dopico - 2022 - Journal of Internal Medicine - Wiley Online Library
Immunogenicity and risks associated with impaired immune responses  following SARS-CoV-2 vaccination and booster in hematologic malignancy  patients: an updated meta-analysis
Frontiers Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
Immunogenicity and risks associated with impaired immune responses  following SARS-CoV-2 vaccination and booster in hematologic malignancy  patients: an updated meta-analysis
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy
Immunogenicity and risks associated with impaired immune responses  following SARS-CoV-2 vaccination and booster in hematologic malignancy  patients: an updated meta-analysis
Covid vaccine efficacy and blood cancer
Immunogenicity and risks associated with impaired immune responses  following SARS-CoV-2 vaccination and booster in hematologic malignancy  patients: an updated meta-analysis
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Immunogenicity and risks associated with impaired immune responses  following SARS-CoV-2 vaccination and booster in hematologic malignancy  patients: an updated meta-analysis
Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis
Immunogenicity and risks associated with impaired immune responses  following SARS-CoV-2 vaccination and booster in hematologic malignancy  patients: an updated meta-analysis
Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis - eBioMedicine

© 2014-2024 remont-grk.ru. All rights reserved.